Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:47 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Rural Lifestyle Eating and Activity Program (Rural LEAP)

ClinicalTrials.gov · NCT02054624 · Registry updated: 2021-09-14

Condition / research focus: Obesity
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2013-08. Completion: 2020-04 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lifestyle intervention (behavioral)
Health education control (behavioral)
Individual (behavioral)
All Groups (behavioral)

Where the study takes place — 14 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Levy County
Bronson, Florida, United States
Site recruitment: Not reported
Flagler County
Bunnell, Florida, United States
Site recruitment: Not reported
Dixie County
Cross City, Florida, United States
Site recruitment: Not reported
Hamilton County
Jasper, Florida, United States
Site recruitment: Not reported
Union County
Lake Butler, Florida, United States
Site recruitment: Not reported
Columbia County
Lake City, Florida, United States
Site recruitment: Not reported
Suwannee County
Live Oak, Florida, United States
Site recruitment: Not reported
Baker County
Macclenny, Florida, United States
Site recruitment: Not reported
Madison County
Madison, Florida, United States
Site recruitment: Not reported
Lafayette County
Mayo, Florida, United States
Site recruitment: Not reported
Putnam County
Palatka, Florida, United States
Site recruitment: Not reported
Taylor County
Perry, Florida, United States
Site recruitment: Not reported
Bradford County
Starke, Florida, United States
Site recruitment: Not reported
Gilchrist County
Trenton, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

ClinicalTrials.gov · NCT03252223 · Registry updated: 2021-09-08

Condition / research focus: Polycystic Ovary Syndrome; Healthy; Anovulation; Hyperandrogenism
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2017-10-02. Completion: 2021-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant Follicle Stimulating Hormone (drug)

Where the study takes place — 1 listed sites

University of California, San Diego
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of Intramural Fibroids on IVF Outcome

ClinicalTrials.gov · NCT03904355 · Registry updated: 2021-08-31

Condition / research focus: Infertility, Female; Assisted Reproduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-05-01. Completion: 2022-05 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins (drug) — also listed as: Ovarian stimulation
human chorionic gonadotropin (drug) — also listed as: Triggering of ovulation
Ovum pick up (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT01573858 · Registry updated: 2021-08-25

Condition / research focus: Pregnancy; Polycystic Ovary Syndrome; Infertility
Sponsor: Heilongjiang University of Chinese Medicine
Countries with listed sites: China
Registry dates and results: Start: 2012-07-06. Completion: 2015-10-07 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Acupuncture treatment 1 (other)
Acupuncture treatment 2 (other)
CC (other)
CC placebo (other)

Where the study takes place — 25 listed sites

First Affiliated Hospital，Anhui University of Chinese Medicine
Hefei, Anhui, China
Site recruitment: Not reported
First Affiliated Hospital，Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China
Site recruitment: Not reported
Guangzhou Liwan Chinese Hospital
Guangzhou, Guangdong, China
Site recruitment: Not reported
Guangdong Chinese Hospital
Guangzhou, Guangdong, China
Site recruitment: Not reported
Daqing LongNa Hospital
Daqing, Heilongjiang, China
Site recruitment: Not reported
The Daqing Oilfield General Hospital
Daqing, Heilongjiang, China
Site recruitment: Not reported
Forth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Site recruitment: Not reported
Second Affiliated Hospital，Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Site recruitment: Not reported
First Affiliated Hospital，Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Site recruitment: Not reported
Henan Chinese Medicine Hospital
Zhengzhou, Henan, China
Site recruitment: Not reported
Wuhan Tongji Hospital
Wuhan, Hubei, China
Site recruitment: Not reported
Hubei Chinese Medicine Hospital
Wuhan, Hubei, China
Site recruitment: Not reported
First Affiliated Hospital，Hunan University of Chinese Medicine
Changsha, Hunan, China
Site recruitment: Not reported
Maternal and Child Health Hospital of Huaian
Huaian, Jiangsu, China
Site recruitment: Not reported
Suzhou Chinese Medicine Hospital
Suzhou, Jiangsu, China
Site recruitment: Not reported
Maternal and Child Health Hospital of Xuzhou
Xuzhou, Jiangsu, China
Site recruitment: Not reported
Jiangxi University of Chinese Medicine Affiliated Hospital
Nanchang, Jiangxi, China
Site recruitment: Not reported
Dalian maternity hospital
Dalian, Liaoning, China
Site recruitment: Not reported
Liaoning University of Chinese Medicine Affiliated Hospital
Shenyang, Liaoning, China
Site recruitment: Not reported
Shanxi Chinese Medicine Hospital
Shangxi, Shanxi, China
Site recruitment: Not reported
First Affiliated Hospital，Tianjin University of Chinese Medicine
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Tianjin Tanggu Maternity and Child Care Center
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Integrated Chinese and Western Medicine Hospital of Zhejiang Province
Hangzhou, Zhejiang, China
Site recruitment: Not reported
Wenzhou Chinese Medicine Hospital
Wenzhou, Zhejiang, China
Site recruitment: Not reported
Hangzhou Chinese Medicine Hospital
Hangzhou, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study

ClinicalTrials.gov · NCT03839511 · Registry updated: 2021-08-19

Condition / research focus: Diabetes
Sponsor: Pennington Biomedical Research Center
Countries with listed sites: United States
Registry dates and results: Start: 2018-11-28. Completion: 2019-02-08 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperinsulinemic-hypoglycemic clamp (procedure)

Where the study takes place — 1 listed sites

Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clearblue Pregnancy Test Lay User Usage Study

ClinicalTrials.gov · NCT04746014 · Registry updated: 2021-08-06

Condition / research focus: Pregnancy
Sponsor: SPD Development Company Limited
Countries with listed sites: United States
Registry dates and results: Start: 2021-02-09. Completion: 2021-08-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clearblue Pregnancy Test (diagnostic_test)

Where the study takes place — 1 listed sites

WCCT
Cypress, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Papillomavirus Load in Rheumatic Inflammatory Diseases

ClinicalTrials.gov · NCT03713736 · Registry updated: 2021-07-27

Condition / research focus: Spondyloarthritis; Rhumatoid Arthisis
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2020-01-09. Completion: 2024-01-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cervical smear (diagnostic_test) — also listed as: HPV test
Pregnancy test (diagnostic_test)
Sexual activity questionnary (behavioral)

Where the study takes place — 3 listed sites

Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France
Bron, France
Site recruitment: Not yet recruiting
Hopital Edouard Herriot - service de rhumatologie
Lyon, France
Site recruitment: Not yet recruiting
Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
Pierre-Bénite, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Expectant Management of Ectopic Pregnancy

ClinicalTrials.gov · NCT04975984 · Registry updated: 2021-07-26

Condition / research focus: Ectopic Pregnancy
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-07-20. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

qualitative hCG levels and ultrasound criteria (diagnostic_test)

Where the study takes place — 1 listed sites

Ain Shams university maternity hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

ClinicalTrials.gov · NCT04224818 · Registry updated: 2021-07-23

Condition / research focus: Poor Ovarian Reserve
Sponsor: American University of Beirut Medical Center
Countries with listed sites: Lebanon
Registry dates and results: Start: 2018-07-11. Completion: 2019-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (drug) — also listed as: Dual ovulation trigger (Choriomon and Triptorelin)
hCG (standard) (drug) — also listed as: human Chorionic Gonadotropin

Where the study takes place — 1 listed sites

American University of Beirut Medical Center
Beirut, Lebanon
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Clinical and Cost Effectiveness of Alpha-Stim AID CES

ClinicalTrials.gov · NCT02901080 · Registry updated: 2021-07-22

Condition / research focus: Anxiety
Sponsor: Electromedical Products International, Inc.
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2016-08-11. Completion: 2017-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (8)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Alpha Stim AID cranial electrotherapy stimulation (device)
Pregnancy test (behavioral)
Anxiety questionnaire (other)
Quality of life questionnaire (other)
Work and social questionnaire (other)
Sleep questionnaire (other)
Depression questionnaire (other)
Quality of life and financial questionnaire (other)

Where the study takes place — 1 listed sites

Leicestershire and Rutland Improving Access to Psychological Therapies (IAPT) Service
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

ClinicalTrials.gov · NCT04483674 · Registry updated: 2021-07-19

Condition / research focus: HIV Primary Infection
Sponsor: Anna Cruceta
Countries with listed sites: Spain
Registry dates and results: Start: 2020-12-04. Completion: 2023-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide (drug) — also listed as: Biktarvy

Where the study takes place — 1 listed sites

Hospital Clinic
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

In Vitro Fertilization Impact on Metabolic Parameters

ClinicalTrials.gov · NCT03426228 · Registry updated: 2021-07-14

Condition / research focus: GDM; Insulin Resistance; Glucose Intolerance; PCOS; Obesity
Sponsor: University of Warwick
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2018-02-15. Completion: 2020-01-05 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HbA1C (diagnostic_test) — also listed as: Lipid profile, Hormonal profile: FSH, LH, progesterone, estrogen,Beta-HCG, Serum Insulin level, Fasting Glucose level, Thyroid-Stimulating Hormone

Where the study takes place — 1 listed sites

Fakih IVF
Dubai, United Arab Emirates
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma

ClinicalTrials.gov · NCT04552964 · Registry updated: 2021-07-14

Condition / research focus: Glaucoma
Sponsor: Laboratoires Thea
Countries with listed sites: France
Registry dates and results: Start: 2020-09-25. Completion: 2021-04-27 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Single arm (other)

Where the study takes place — 1 listed sites

Centre d'Ophtalmologie Blatin
Clermont-Ferrand, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Women First: Preconception Maternal Nutrition

ClinicalTrials.gov · NCT01883193 · Registry updated: 2021-07-08

Condition / research focus: Maternal Malnutrition; Growth Failure; Mortality; Morbidity; Stunting
Sponsor: University of Colorado, Denver
Countries with listed sites: Democratic Republic of the Congo · Guatemala · India · Pakistan
Registry dates and results: Start: 2013-08. Completion: 2019-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comprehensive Maternal Nutrition Intervention (dietary_supplement) — also listed as: multi micronutrient (MMN) fortified lipid-based supplement, lipid-based nutrient supplement, LNS

Where the study takes place — 4 listed sites

Kinshasa School of Public Health
Kinshasa, Democratic Republic of the Congo
Site recruitment: Not reported
INCAP
Guatemala City, Guatemala
Site recruitment: Not reported
Jawaharlal Nehru Medical College
Belagavi, India
Site recruitment: Not reported
Aga Khan University
Karachi, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Different Treatment Options for Tubal Ectopic Pregnancy:- A Systmatic Review

ClinicalTrials.gov · NCT04951011 · Registry updated: 2021-07-06

Condition / research focus: Woman With Tubal Ectopic Pregnancy
Sponsor: Sohag University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-07-01. Completion: 2022-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Serum beta HCG (diagnostic_test)

Where the study takes place — 1 listed sites

Sohag
Akhmīm, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.

ClinicalTrials.gov · NCT03915054 · Registry updated: 2021-06-16

Condition / research focus: PCOS; IVM
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2019-04-17. Completion: 2020-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AREG-TRIGGER (drug) — also listed as: Capacitation IVM medium
CONTROL-TRIGGER (drug) — also listed as: CAPA Control Medium

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

B-HCG Levels in Women Diagnosed With Retained Products of Conception

ClinicalTrials.gov · NCT04917016 · Registry updated: 2021-06-08

Condition / research focus: Retained Products of Conception
Sponsor: Assaf-Harofeh Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2019-12-01. Completion: 2021-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Plasma B-HCG levels (diagnostic_test)

Where the study takes place — 1 listed sites

Shamir Medical Center
Be’er Ya‘aqov, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

ClinicalTrials.gov · NCT01297465 · Registry updated: 2021-05-28

Condition / research focus: Assisted Reproductive Techniques; Reproductive Technology, Assisted
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Denmark · Finland · France · Germany · Greece · Italy · Netherlands · Poland · Russia · Slovakia · United Kingdom
Registry dates and results: Start: 2011-05-31. Completion: 2012-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal-f® (drug) — also listed as: Follitropin alfa
Pergoveris® (drug)
Pergoveris® (drug)
Recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel®, Ovitrelle®

Where the study takes place — 23 listed sites

Research Site
Dronninglund, Denmark
Site recruitment: Not reported
Research Site
Fredericia, Denmark
Site recruitment: Not reported
Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Bondy, France
Site recruitment: Not reported
Research Site
Bruges, France
Site recruitment: Not reported
Research Site
Clamart, France
Site recruitment: Not reported
Research Site
Thenon, France
Site recruitment: Not reported
Research Site
Villeurbanne, France
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Halle, Germany
Site recruitment: Not reported
Research Site
Heraklion, Crete, Greece
Site recruitment: Not reported
Research Site
Pylaia, Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Bologna, Italy
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Torino, Italy
Site recruitment: Not reported
Research Site
Zwolle, Netherlands
Site recruitment: Not reported
Research Site
Warsaw, Poland
Site recruitment: Not reported
Research Site
Moscow, Russia
Site recruitment: Not reported
Research Site
Samara, Russia
Site recruitment: Not reported
Research Site
Bratislava, Slovakia
Site recruitment: Not reported
Research Site
London, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Evaluation of a Mobile Preconception Lifestyle Programme in Couples Undergoing In Vitro Fertilisation

ClinicalTrials.gov · NCT03790449 · Registry updated: 2021-05-10

Condition / research focus: Infertility
Sponsor: Universitaire Ziekenhuizen KU Leuven
Countries with listed sites: Belgium
Registry dates and results: Start: 2019-01-02. Completion: 2021-03-13 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

PreLiFe-programme (behavioral)
Attention Control Programme (behavioral)

Where the study takes place — 5 listed sites

University Hospital Antwerp
Antwerp, Belgium
Site recruitment: Not reported
Imelda Hospital Bonheiden
Bonheiden, Belgium
Site recruitment: Not reported
Academic Hospital Sint Jan Bruges-Ostend
Bruges, Belgium
Site recruitment: Not reported
Academic Hospital Diest
Diest, Belgium
Site recruitment: Not reported
University Hospitals Leuven
Leuven, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

ClinicalTrials.gov · NCT04870502 · Registry updated: 2021-05-03

Condition / research focus: Polycystic Ovarian Syndrome
Sponsor: Saudi German Hospital - Madinah
Countries with listed sites: Saudi Arabia
Registry dates and results: Start: 2019-04-01. Completion: 2020-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Controlled ovarian stimulation by Combined Clomiphene Citrate and Ubiquinol Versus hMG (drug) — also listed as: Fertab® 50 mg tablets, Zynova. SITCO Pharma., Nutraquinol®; Jamjoom Pharma Nutraceuticals, Merional® 75 I.U. vials, IBSA

Where the study takes place — 1 listed sites

Saudi German Hospital
Al Madīnah, Madinah, Saudi Arabia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:47 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Rural Lifestyle Eating and Activity Program (Rural LEAP)

ClinicalTrials.gov · NCT02054624 · Registry updated: 2021-09-14

Condition / research focus: Obesity
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2013-08. Completion: 2020-04 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lifestyle intervention (behavioral)
Health education control (behavioral)
Individual (behavioral)
All Groups (behavioral)

Where the study takes place — 14 listed sites

Levy County
Bronson, Florida, United States
Site recruitment: Not reported
Flagler County
Bunnell, Florida, United States
Site recruitment: Not reported
Dixie County
Cross City, Florida, United States
Site recruitment: Not reported
Hamilton County
Jasper, Florida, United States
Site recruitment: Not reported
Union County
Lake Butler, Florida, United States
Site recruitment: Not reported
Columbia County
Lake City, Florida, United States
Site recruitment: Not reported
Suwannee County
Live Oak, Florida, United States
Site recruitment: Not reported
Baker County
Macclenny, Florida, United States
Site recruitment: Not reported
Madison County
Madison, Florida, United States
Site recruitment: Not reported
Lafayette County
Mayo, Florida, United States
Site recruitment: Not reported
Putnam County
Palatka, Florida, United States
Site recruitment: Not reported
Taylor County
Perry, Florida, United States
Site recruitment: Not reported
Bradford County
Starke, Florida, United States
Site recruitment: Not reported
Gilchrist County
Trenton, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

ClinicalTrials.gov · NCT03252223 · Registry updated: 2021-09-08

Condition / research focus: Polycystic Ovary Syndrome; Healthy; Anovulation; Hyperandrogenism
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2017-10-02. Completion: 2021-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Recombinant Follicle Stimulating Hormone (drug)

Where the study takes place — 1 listed sites

University of California, San Diego
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of Intramural Fibroids on IVF Outcome

ClinicalTrials.gov · NCT03904355 · Registry updated: 2021-08-31

Condition / research focus: Infertility, Female; Assisted Reproduction
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-05-01. Completion: 2022-05 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins (drug) — also listed as: Ovarian stimulation
human chorionic gonadotropin (drug) — also listed as: Triggering of ovulation
Ovum pick up (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT01573858 · Registry updated: 2021-08-25

Condition / research focus: Pregnancy; Polycystic Ovary Syndrome; Infertility
Sponsor: Heilongjiang University of Chinese Medicine
Countries with listed sites: China
Registry dates and results: Start: 2012-07-06. Completion: 2015-10-07 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Acupuncture treatment 1 (other)
Acupuncture treatment 2 (other)
CC (other)
CC placebo (other)

Where the study takes place — 25 listed sites

First Affiliated Hospital，Anhui University of Chinese Medicine
Hefei, Anhui, China
Site recruitment: Not reported
First Affiliated Hospital，Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China
Site recruitment: Not reported
Guangzhou Liwan Chinese Hospital
Guangzhou, Guangdong, China
Site recruitment: Not reported
Guangdong Chinese Hospital
Guangzhou, Guangdong, China
Site recruitment: Not reported
Daqing LongNa Hospital
Daqing, Heilongjiang, China
Site recruitment: Not reported
The Daqing Oilfield General Hospital
Daqing, Heilongjiang, China
Site recruitment: Not reported
Forth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Site recruitment: Not reported
Second Affiliated Hospital，Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Site recruitment: Not reported
First Affiliated Hospital，Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Site recruitment: Not reported
Henan Chinese Medicine Hospital
Zhengzhou, Henan, China
Site recruitment: Not reported
Wuhan Tongji Hospital
Wuhan, Hubei, China
Site recruitment: Not reported
Hubei Chinese Medicine Hospital
Wuhan, Hubei, China
Site recruitment: Not reported
First Affiliated Hospital，Hunan University of Chinese Medicine
Changsha, Hunan, China
Site recruitment: Not reported
Maternal and Child Health Hospital of Huaian
Huaian, Jiangsu, China
Site recruitment: Not reported
Suzhou Chinese Medicine Hospital
Suzhou, Jiangsu, China
Site recruitment: Not reported
Maternal and Child Health Hospital of Xuzhou
Xuzhou, Jiangsu, China
Site recruitment: Not reported
Jiangxi University of Chinese Medicine Affiliated Hospital
Nanchang, Jiangxi, China
Site recruitment: Not reported
Dalian maternity hospital
Dalian, Liaoning, China
Site recruitment: Not reported
Liaoning University of Chinese Medicine Affiliated Hospital
Shenyang, Liaoning, China
Site recruitment: Not reported
Shanxi Chinese Medicine Hospital
Shangxi, Shanxi, China
Site recruitment: Not reported
First Affiliated Hospital，Tianjin University of Chinese Medicine
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Tianjin Tanggu Maternity and Child Care Center
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Integrated Chinese and Western Medicine Hospital of Zhejiang Province
Hangzhou, Zhejiang, China
Site recruitment: Not reported
Wenzhou Chinese Medicine Hospital
Wenzhou, Zhejiang, China
Site recruitment: Not reported
Hangzhou Chinese Medicine Hospital
Hangzhou, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study

ClinicalTrials.gov · NCT03839511 · Registry updated: 2021-08-19

Condition / research focus: Diabetes
Sponsor: Pennington Biomedical Research Center
Countries with listed sites: United States
Registry dates and results: Start: 2018-11-28. Completion: 2019-02-08 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperinsulinemic-hypoglycemic clamp (procedure)

Where the study takes place — 1 listed sites

Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clearblue Pregnancy Test Lay User Usage Study

ClinicalTrials.gov · NCT04746014 · Registry updated: 2021-08-06

Condition / research focus: Pregnancy
Sponsor: SPD Development Company Limited
Countries with listed sites: United States
Registry dates and results: Start: 2021-02-09. Completion: 2021-08-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clearblue Pregnancy Test (diagnostic_test)

Where the study takes place — 1 listed sites

WCCT
Cypress, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Papillomavirus Load in Rheumatic Inflammatory Diseases

ClinicalTrials.gov · NCT03713736 · Registry updated: 2021-07-27

Condition / research focus: Spondyloarthritis; Rhumatoid Arthisis
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2020-01-09. Completion: 2024-01-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cervical smear (diagnostic_test) — also listed as: HPV test
Pregnancy test (diagnostic_test)
Sexual activity questionnary (behavioral)

Where the study takes place — 3 listed sites

Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France
Bron, France
Site recruitment: Not yet recruiting
Hopital Edouard Herriot - service de rhumatologie
Lyon, France
Site recruitment: Not yet recruiting
Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
Pierre-Bénite, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Expectant Management of Ectopic Pregnancy

ClinicalTrials.gov · NCT04975984 · Registry updated: 2021-07-26

Condition / research focus: Ectopic Pregnancy
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-07-20. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

qualitative hCG levels and ultrasound criteria (diagnostic_test)

Where the study takes place — 1 listed sites

Ain Shams university maternity hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

ClinicalTrials.gov · NCT04224818 · Registry updated: 2021-07-23

Condition / research focus: Poor Ovarian Reserve
Sponsor: American University of Beirut Medical Center
Countries with listed sites: Lebanon
Registry dates and results: Start: 2018-07-11. Completion: 2019-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dual trigger (drug) — also listed as: Dual ovulation trigger (Choriomon and Triptorelin)
hCG (standard) (drug) — also listed as: human Chorionic Gonadotropin

Where the study takes place — 1 listed sites

American University of Beirut Medical Center
Beirut, Lebanon
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Clinical and Cost Effectiveness of Alpha-Stim AID CES

ClinicalTrials.gov · NCT02901080 · Registry updated: 2021-07-22

Condition / research focus: Anxiety
Sponsor: Electromedical Products International, Inc.
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2016-08-11. Completion: 2017-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (8)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Alpha Stim AID cranial electrotherapy stimulation (device)
Pregnancy test (behavioral)
Anxiety questionnaire (other)
Quality of life questionnaire (other)
Work and social questionnaire (other)
Sleep questionnaire (other)
Depression questionnaire (other)
Quality of life and financial questionnaire (other)

Where the study takes place — 1 listed sites

Leicestershire and Rutland Improving Access to Psychological Therapies (IAPT) Service
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

ClinicalTrials.gov · NCT04483674 · Registry updated: 2021-07-19

Condition / research focus: HIV Primary Infection
Sponsor: Anna Cruceta
Countries with listed sites: Spain
Registry dates and results: Start: 2020-12-04. Completion: 2023-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide (drug) — also listed as: Biktarvy

Where the study takes place — 1 listed sites

Hospital Clinic
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

In Vitro Fertilization Impact on Metabolic Parameters

ClinicalTrials.gov · NCT03426228 · Registry updated: 2021-07-14

Condition / research focus: GDM; Insulin Resistance; Glucose Intolerance; PCOS; Obesity
Sponsor: University of Warwick
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2018-02-15. Completion: 2020-01-05 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HbA1C (diagnostic_test) — also listed as: Lipid profile, Hormonal profile: FSH, LH, progesterone, estrogen,Beta-HCG, Serum Insulin level, Fasting Glucose level, Thyroid-Stimulating Hormone

Where the study takes place — 1 listed sites

Fakih IVF
Dubai, United Arab Emirates
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma

ClinicalTrials.gov · NCT04552964 · Registry updated: 2021-07-14

Condition / research focus: Glaucoma
Sponsor: Laboratoires Thea
Countries with listed sites: France
Registry dates and results: Start: 2020-09-25. Completion: 2021-04-27 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Single arm (other)

Where the study takes place — 1 listed sites

Centre d'Ophtalmologie Blatin
Clermont-Ferrand, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Women First: Preconception Maternal Nutrition

ClinicalTrials.gov · NCT01883193 · Registry updated: 2021-07-08

Condition / research focus: Maternal Malnutrition; Growth Failure; Mortality; Morbidity; Stunting
Sponsor: University of Colorado, Denver
Countries with listed sites: Democratic Republic of the Congo · Guatemala · India · Pakistan
Registry dates and results: Start: 2013-08. Completion: 2019-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comprehensive Maternal Nutrition Intervention (dietary_supplement) — also listed as: multi micronutrient (MMN) fortified lipid-based supplement, lipid-based nutrient supplement, LNS

Where the study takes place — 4 listed sites

Kinshasa School of Public Health
Kinshasa, Democratic Republic of the Congo
Site recruitment: Not reported
INCAP
Guatemala City, Guatemala
Site recruitment: Not reported
Jawaharlal Nehru Medical College
Belagavi, India
Site recruitment: Not reported
Aga Khan University
Karachi, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Different Treatment Options for Tubal Ectopic Pregnancy:- A Systmatic Review

ClinicalTrials.gov · NCT04951011 · Registry updated: 2021-07-06

Condition / research focus: Woman With Tubal Ectopic Pregnancy
Sponsor: Sohag University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-07-01. Completion: 2022-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Serum beta HCG (diagnostic_test)

Where the study takes place — 1 listed sites

Sohag
Akhmīm, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.

ClinicalTrials.gov · NCT03915054 · Registry updated: 2021-06-16

Condition / research focus: PCOS; IVM
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2019-04-17. Completion: 2020-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AREG-TRIGGER (drug) — also listed as: Capacitation IVM medium
CONTROL-TRIGGER (drug) — also listed as: CAPA Control Medium

Where the study takes place — 1 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

B-HCG Levels in Women Diagnosed With Retained Products of Conception

ClinicalTrials.gov · NCT04917016 · Registry updated: 2021-06-08

Condition / research focus: Retained Products of Conception
Sponsor: Assaf-Harofeh Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2019-12-01. Completion: 2021-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Plasma B-HCG levels (diagnostic_test)

Where the study takes place — 1 listed sites

Shamir Medical Center
Be’er Ya‘aqov, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

ClinicalTrials.gov · NCT01297465 · Registry updated: 2021-05-28

Condition / research focus: Assisted Reproductive Techniques; Reproductive Technology, Assisted
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Denmark · Finland · France · Germany · Greece · Italy · Netherlands · Poland · Russia · Slovakia · United Kingdom
Registry dates and results: Start: 2011-05-31. Completion: 2012-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonal-f® (drug) — also listed as: Follitropin alfa
Pergoveris® (drug)
Pergoveris® (drug)
Recombinant human chorionic gonadotropin (r-hCG) (drug) — also listed as: Ovidrel®, Ovitrelle®

Where the study takes place — 23 listed sites

Research Site
Dronninglund, Denmark
Site recruitment: Not reported
Research Site
Fredericia, Denmark
Site recruitment: Not reported
Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Bondy, France
Site recruitment: Not reported
Research Site
Bruges, France
Site recruitment: Not reported
Research Site
Clamart, France
Site recruitment: Not reported
Research Site
Thenon, France
Site recruitment: Not reported
Research Site
Villeurbanne, France
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Halle, Germany
Site recruitment: Not reported
Research Site
Heraklion, Crete, Greece
Site recruitment: Not reported
Research Site
Pylaia, Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Bologna, Italy
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Torino, Italy
Site recruitment: Not reported
Research Site
Zwolle, Netherlands
Site recruitment: Not reported
Research Site
Warsaw, Poland
Site recruitment: Not reported
Research Site
Moscow, Russia
Site recruitment: Not reported
Research Site
Samara, Russia
Site recruitment: Not reported
Research Site
Bratislava, Slovakia
Site recruitment: Not reported
Research Site
London, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Evaluation of a Mobile Preconception Lifestyle Programme in Couples Undergoing In Vitro Fertilisation

ClinicalTrials.gov · NCT03790449 · Registry updated: 2021-05-10

Condition / research focus: Infertility
Sponsor: Universitaire Ziekenhuizen KU Leuven
Countries with listed sites: Belgium
Registry dates and results: Start: 2019-01-02. Completion: 2021-03-13 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

PreLiFe-programme (behavioral)
Attention Control Programme (behavioral)

Where the study takes place — 5 listed sites

University Hospital Antwerp
Antwerp, Belgium
Site recruitment: Not reported
Imelda Hospital Bonheiden
Bonheiden, Belgium
Site recruitment: Not reported
Academic Hospital Sint Jan Bruges-Ostend
Bruges, Belgium
Site recruitment: Not reported
Academic Hospital Diest
Diest, Belgium
Site recruitment: Not reported
University Hospitals Leuven
Leuven, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

ClinicalTrials.gov · NCT04870502 · Registry updated: 2021-05-03

Condition / research focus: Polycystic Ovarian Syndrome
Sponsor: Saudi German Hospital - Madinah
Countries with listed sites: Saudi Arabia
Registry dates and results: Start: 2019-04-01. Completion: 2020-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Controlled ovarian stimulation by Combined Clomiphene Citrate and Ubiquinol Versus hMG (drug) — also listed as: Fertab® 50 mg tablets, Zynova. SITCO Pharma., Nutraquinol®; Jamjoom Pharma Nutraceuticals, Merional® 75 I.U. vials, IBSA

Where the study takes place — 1 listed sites

Saudi German Hospital
Al Madīnah, Madinah, Saudi Arabia
Site recruitment: Not reported

Original record, eligibility, contacts and results →